[go: up one dir, main page]

CY1114036T1 - Φαρμακοτεχνικη μορφη που περιεχει κετοπροφενη και εναν εστερα πολυοξυαλκυλενιου ενος υδροξυ λιπαρου οξεος - Google Patents

Φαρμακοτεχνικη μορφη που περιεχει κετοπροφενη και εναν εστερα πολυοξυαλκυλενιου ενος υδροξυ λιπαρου οξεος

Info

Publication number
CY1114036T1
CY1114036T1 CY20131100309T CY131100309T CY1114036T1 CY 1114036 T1 CY1114036 T1 CY 1114036T1 CY 20131100309 T CY20131100309 T CY 20131100309T CY 131100309 T CY131100309 T CY 131100309T CY 1114036 T1 CY1114036 T1 CY 1114036T1
Authority
CY
Cyprus
Prior art keywords
fatty acid
polyoxylylene
hydroxy fatty
pharmaceutical form
ketoprofen
Prior art date
Application number
CY20131100309T
Other languages
English (en)
Inventor
Michele Virno
Original Assignee
Lectio Pharmaentwicklungs-Und Verwertungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lectio Pharmaentwicklungs-Und Verwertungs Gmbh filed Critical Lectio Pharmaentwicklungs-Und Verwertungs Gmbh
Publication of CY1114036T1 publication Critical patent/CY1114036T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μία φαρμακοτεχνική μορφή που περιέχει (i) κετοπροφένη, (ii) τουλάχιστον έναν εστέρα πολυοξυαλκυλενίου ενός υδροξυ λιπαρού οξέος, (iii) τουλάχιστον μία υδροξυ υποκατεστημένη οργανική ομάδα που επιλέγεται από την ομάδα που αποτελείται από τουλάχιστον μία αλκοόλη, τουλάχιστον μία πολυόλη και μίγματα αυτών, και (iv) νερό.
CY20131100309T 2009-03-12 2013-04-12 Φαρμακοτεχνικη μορφη που περιεχει κετοπροφενη και εναν εστερα πολυοξυαλκυλενιου ενος υδροξυ λιπαρου οξεος CY1114036T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09155046 2009-03-12
EP10701698A EP2405892B1 (en) 2009-03-12 2010-02-02 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid

Publications (1)

Publication Number Publication Date
CY1114036T1 true CY1114036T1 (el) 2016-07-27

Family

ID=40549651

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100309T CY1114036T1 (el) 2009-03-12 2013-04-12 Φαρμακοτεχνικη μορφη που περιεχει κετοπροφενη και εναν εστερα πολυοξυαλκυλενιου ενος υδροξυ λιπαρου οξεος

Country Status (18)

Country Link
EP (1) EP2405892B1 (el)
AU (1) AU2010223495B2 (el)
BR (1) BRPI1008983A2 (el)
CA (1) CA2752713C (el)
CL (1) CL2011002225A1 (el)
CY (1) CY1114036T1 (el)
DK (1) DK2405892T3 (el)
EA (1) EA019992B1 (el)
ES (1) ES2403380T3 (el)
HR (1) HRP20130304T1 (el)
IL (1) IL214676A (el)
MX (1) MX2011009509A (el)
NZ (1) NZ594646A (el)
PL (1) PL2405892T3 (el)
PT (1) PT2405892E (el)
SI (1) SI2405892T1 (el)
SM (1) SMT201300035B (el)
WO (1) WO2010102862A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116637069B (zh) * 2023-07-19 2023-09-19 成都金瑞基业生物科技有限公司 一种和厚朴酚脂质体透皮凝胶剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (el) * 1982-10-07 1986-05-15
ATE223202T1 (de) 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
IT1270678B (it) 1994-10-20 1997-05-07 Bayer Ag Liposomi al chetoprofen
US5654337A (en) 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
IT1277430B1 (it) * 1995-08-03 1997-11-10 Bayer Italia Spa Preparazioni farmaceutiche per uso topico a base di ketoprofene
US5902110A (en) 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
US5885597A (en) 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
US6083996A (en) 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
EA201171124A1 (ru) 2012-02-28
AU2010223495B2 (en) 2014-12-18
MX2011009509A (es) 2012-01-20
NZ594646A (en) 2013-12-20
PT2405892E (pt) 2013-04-15
EP2405892A1 (en) 2012-01-18
HRP20130304T1 (en) 2013-05-31
EP2405892B1 (en) 2013-01-16
PL2405892T3 (pl) 2013-10-31
ES2403380T3 (es) 2013-05-17
SMT201300035B (it) 2013-07-09
CA2752713C (en) 2017-01-03
BRPI1008983A2 (pt) 2016-03-22
IL214676A (en) 2014-09-30
DK2405892T3 (da) 2013-04-08
CL2011002225A1 (es) 2012-07-13
AU2010223495A1 (en) 2011-09-08
WO2010102862A1 (en) 2010-09-16
CA2752713A1 (en) 2010-09-16
EA019992B1 (ru) 2014-07-30
SI2405892T1 (sl) 2013-06-28
IL214676A0 (en) 2011-09-27

Similar Documents

Publication Publication Date Title
CY1119784T1 (el) Ακετυλιωμενες σαλικυλικες ενωσεις λιπαρου οξεος και οι χρησεις αυτων
CY1123549T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
CY1117367T1 (el) Αντινοηματικο νουκλεϊνικο οξυ
MX352328B (es) Formulaciones orales de ester de testosterona y metodos para el tratamiento de la deficiencia de testosterona que comprende estos.
NI201200038A (es) Conjugados de niacina y ácidos grasos y sus usos
EP2512522A4 (en) PARTICLES FOR ADMINISTRATION OF MULTIPLE AGENTS
CY1117847T1 (el) Φαρμακευτικο σκευασμα που περιλαμβανει ενα ή περισσοτερους εστερες φουμαρικου οξεος σε μητρα διαβρωσης
ES2488407T3 (es) Preparación farmacéutica que contiene lipasa de origen bacteriano
LT3037089T (lt) Eikozapentaeno rūgšties etilo esteris skirtas hipertriglicidemijai gydydti
ECSP12012097A (es) Derivados de fumarato de ácido graso y sus usos
IT1393045B1 (it) Composizioni contenenti monogliceridi di acidi organici da c1 a c7 e glicerolo, loro preparazione ed uso come antibatterici in zootecnia.
EP2348844A4 (en) BIOMATERIALS BASED ON RETICULATED FATTY ACIDS
BR112012012108A2 (pt) composição farmacêutica compreendendo propofol
FR2948568B1 (fr) Formulation pharmaceutique
UY32944A (es) Compuestos poliméricos de ésteres silil benzoicos, sus usos y composiciones
EA201100863A1 (ru) Фармацевтическая композиция, включающая диклофенак и сложный эфир гидроксижирной кислоты и полиоксиалкилена
GT200600463A (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
CL2011002229A1 (es) Formulacion farmaceutica que comprende un compuesto activo miembro de la familia de las calcitoninas que no es amilina.
PE20181493A1 (es) Profarmaco de adrenomedulina basado en polietilenglicol y su uso
CR20110219A (es) Ácidos naftilacéticos
BRPI0914410A2 (pt) composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares.
EP2444087A4 (en) PHARMACEUTICAL COMPOSITION WITH IMPROVED SOLUBILITY
BRPI0908847A2 (pt) sistema de reforço de turbina
IN2014CN03214A (el)
BRPI1014928A2 (pt) ácido levulínico proveniente de biomassa fúngica.